J&J Leverages Novel Mechanisms In Neuropsychiatry, Neurodegeneration

 
• By Mandy Jackson

Janssen Neuroscience therapeutic area head Husseini Manji describes near-, mid- and long-term milestones among J&J's potential blockbusters, including an every six months injection for schizophrenia, Spravato for suicidal ideation, and earlier programs in Alzheimer's disease.

Neuroscience development and training concept as a group of cog wheels and gears shaped as human head with information transfer as a technology brain symbol or psychology exchange as a 3D render. - Illustration
Scrip spoke with Janssen Neuroscience's Husseini Manji. • Source: Shutterstock

More from Neurological

More from Therapy Areas